Javascript must be enabled to continue!
Introducing the New <i>Tangut Literature Series (TLS)</i>
View through CrossRef
This article introduces the first ten texts published in colour in the new Tangut Literature Series (TLS) started in 2021 jointly by the Ningxia University, China, and the Institute of Oriental Manuscripts of the Russian Academy of Sciences. All ten works of exceptionally high research value have been thoroughly studied and were published in black and white in 1990s in the collection titled Heishuicheng Manuscripts Collected in Russia. Their publication in the new TLS series is important as it makes visible all the colour stamps and punctuation marks on the manuscripts and woodprints.
Institute of Oriental Manuscripts of the Russian Academy of Sciences
Title: Introducing the New <i>Tangut Literature Series (TLS)</i>
Description:
This article introduces the first ten texts published in colour in the new Tangut Literature Series (TLS) started in 2021 jointly by the Ningxia University, China, and the Institute of Oriental Manuscripts of the Russian Academy of Sciences.
All ten works of exceptionally high research value have been thoroughly studied and were published in black and white in 1990s in the collection titled Heishuicheng Manuscripts Collected in Russia.
Their publication in the new TLS series is important as it makes visible all the colour stamps and punctuation marks on the manuscripts and woodprints.
Related Results
Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer
Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer
Abstract
Background & aims: Tertiary lymphoid structures (TLSs[1]) are predictive biomarkers of favorable clinical outcomes and immunotherapy response in several solid ...
Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer
Immature central tumor tertiary lymphoid structures are associated with better prognosis in non-small cell lung cancer
Abstract
Background & aims
Tertiary lymphoid structures (TLSs) are predictive biomarkers of favorable clinical outcomes and immunotherapy respon...
Protein Assemblies in Translesion Synthesis
Protein Assemblies in Translesion Synthesis
Translesion synthesis (TLS) is a mechanism of DNA damage tolerance utilized by eukaryotic cells to replicate DNA across lesions that impede the high-fidelity replication machinery....
Abstract 18257: Arrhythmias in Tumor Lysis Syndrome
Abstract 18257: Arrhythmias in Tumor Lysis Syndrome
Background:
Tumor lysis syndrome (TLS) is a common complication seen among hospitalized patients with acute promyelocytic leukemia (APL) undergoing induction therapy.
...
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
Defining heterogeneity in the immune infiltrate of gastroesophageal adenocarcinoma
Defining heterogeneity in the immune infiltrate of gastroesophageal adenocarcinoma
Gastro-esophageal adenocarcinoma (GEAC) is a cancer with a poor prognosis and limited treatment options. Most patients present with metastatic disease, where systemic therapies off...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures
Tumor immune microenvironment of cutaneous angiosarcoma with cancer testis antigens and the formation of tertiary lymphoid structures
Cutaneous angiosarcoma (CAS) is a highly malignant tumor with few effective treatments. Although the indication for immune checkpoint inhibitors such as anti-PD-1 antibodies is exp...

